Show Filters

Searches all publications.

Search Fulltext



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-20
    E.g., 2018-09-20


70 items
12:00 AM, Aug 04, 2016  |  BC Innovations | Finance

2Q16 Public-Private Partnership Roundup

A new consortia revival helped boost public-private partnerships (PPPs) in 2Q16 to the highest total in two years. Newly announced preclinically focused deals jumped 30% over the relatively sluggish first quarter, from 56 PPPs to...
12:00 AM, Jul 28, 2016  |  BC Innovations | Finance

MRCT looks east

MRC Technology (MRCT) is broadening its reach to Asia with a new strategy that extends beyond the source and geography of its original mission to serve as the tech transfer arm of the U.K.'s Medical...
12:00 AM, Jun 30, 2016  |  BC Innovations | Finance

It takes M2

Mark Zipkin, Staff Writer  Two Melbourne-based universities are creating an independent investment vehicle to boost basic research coming out of local labs and build a translational ecosystem in southeastern Australia and beyond. While the enterprise, M2...
12:00 AM, May 19, 2016  |  BC Innovations | Finance

Found in translation

Mark Zipkin, Staff Writer  With almost $1 billion in new venture funds in the last year and a half aimed at academic research, Europe is showing signs of a dedicated effort among investors and universities alike...
12:00 AM, Apr 28, 2016  |  BC Innovations | Finance

Public-Private Partnership Roundup

Public-private partnerships (PPPs) continue to accumulate at a high rate in the preclinical space, with 56 deals disclosed in 1Q16, but the data suggest the nature of the deals is moving away from large disease-centric...
12:00 AM, Apr 28, 2016  |  BC Innovations | Finance

Virtually biotechs

Harvard University's $20 million licensing deal with Merck & Co. Inc in March for a preclinical cancer therapy brought in more cash in one swoop than the university's tech transfer office saw in all of...
12:00 AM, Apr 28, 2016  |  BC Innovations | Finance

Bridging translation

An increasing number of academic institutions are filling the translational gap between what typical academic projects produce and what companies or VC firms want to see in order to commercialize a discovery. These organizations, or...
12:00 AM, Apr 07, 2016  |  BC Innovations | Finance

Public Funding Notebook: Transparency from outside

NIH's new deputy director for extramural research has set improving transparency as his banner priority, focusing in particular on the process for awarding grants and accountability over public funds. Michael Lauer, who replaced Sally Rockey...
12:00 AM, Feb 04, 2016  |  BC Innovations | Finance

PPP tipping point

For the past five years, BioCentury Innovations has tracked the formation of new public-private partnerships (PPPs) to follow how biotechs and pharmas are using research partnerships to access academic innovation. While the 2015 data show...
12:00 AM, Jan 21, 2016  |  BC Innovations | Finance

Italy's velocity factor

After five years of building a portfolio of research programs, Italian tech transfer company TTFactor s.r.l. can now turn to a homegrown supply of seed funding following the launch of BiovelocITA, the country's first biotech...